Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
DexCom Community
NasdaqGS:DXCM Community
1
Narratives
written by author
1
Comments
on narratives written by author
87
Fair Values set
on narratives written by author
Create a narrative
DexCom
Popular
Undervalued
Overvalued
Community Investing Ideas
DexCom
AN
AnalystConsensusTarget
Consensus Narrative from 26 Analysts
New G7 And Stelo Launches Will Shape Future Markets
Key Takeaways Expansion of prescriber base and new over-the-counter CGM products are poised to boost revenue and improve net margins through wider market penetration. Coverage expansion by major PBMs and product advancements like the Dexcom G7 System are key revenue growth drivers, backed by a significant share repurchase program.
View narrative
US$98.85
FV
12.3% undervalued
intrinsic discount
15.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
47
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
DXCM
DXCM
DexCom
Your Fair Value
US$
Current Price
US$86.74
31.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-130m
8b
2015
2018
2021
2024
2025
2027
2030
Revenue US$7.7b
Earnings US$991.0m
Advanced
Set Fair Value